$146 Million is the total value of Sio Capital Management, LLC's 35 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 69.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QTNT | Buy | QUOTIENT ORDwarrant | $16,668,000 | +3.1% | 1,580,457 | +44.6% | 11.42% | +43.0% |
| NEOS | New | NEOS THERAPEUTICS ORD | $14,008,000 | – | 666,729 | +100.0% | 9.60% | – |
| JNJ | Buy | JOHNSON & JOHNSON ORD | $7,976,000 | +27.5% | 85,438 | +33.1% | 5.47% | +76.9% |
| MDT | Buy | MEDTRONIC ORD | $7,584,000 | +84.8% | 113,289 | +104.5% | 5.20% | +156.3% |
| CAH | Buy | CARDINAL HEALTH ORD | $7,288,000 | +37.7% | 94,868 | +49.9% | 5.00% | +91.1% |
| UNH | New | UNITEDHEALTH GRP ORD | $6,495,000 | – | 55,984 | +100.0% | 4.45% | – |
| SNY | New | SANOFI ORD | $6,231,000 | – | 131,271 | +100.0% | 4.27% | – |
| CI | Buy | CIGNA ORD | $6,142,000 | +114.9% | 45,493 | +157.9% | 4.21% | +198.2% |
| RXDX | Buy | IGNYTA ORD | $5,991,000 | -24.0% | 682,306 | +30.5% | 4.11% | +5.4% |
| AMGN | Buy | AMGEN ORD | $5,233,000 | +20.2% | 37,832 | +33.5% | 3.59% | +66.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS ORD | $5,223,000 | +61.4% | 64,996 | +140.7% | 3.58% | +123.9% |
| ANTH | Buy | ANTHERA PHARMACEUTICALS ORD | $5,213,000 | +153.9% | 856,072 | +259.5% | 3.57% | +252.4% |
| ABBV | Buy | ABBVIE ORD | $5,132,000 | +129.4% | 94,316 | +183.3% | 3.52% | +218.4% |
| ADMP | Buy | ADAMIS PHARMACEUTICALS ORD | $5,058,000 | -1.5% | 1,306,860 | +6.9% | 3.47% | +36.7% |
| UTHR | New | UNITED THERAPEUTICS ORD | $4,945,000 | – | 37,677 | +100.0% | 3.39% | – |
| BMY | New | BRISTOL MYERS SQUIBB ORD | $4,898,000 | – | 82,734 | +100.0% | 3.36% | – |
| ASND | Buy | ASCENDIS PHARMA ADR REP ORDadr | $4,775,000 | +33.3% | 269,785 | +33.2% | 3.27% | +85.0% |
| FLML | Sell | FLAMEL TECHNOLOGIES ADR REP 1 ORDadr | $3,909,000 | -42.4% | 239,698 | -25.1% | 2.68% | -20.0% |
| PFNX | Sell | PFENEX ORD | $3,832,000 | -42.9% | 255,303 | -26.2% | 2.63% | -20.8% |
| ACHN | Buy | ACHILLION PHARMACEUTICALS ORD | $2,518,000 | +15.1% | 364,368 | +47.5% | 1.73% | +59.7% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS ORD | $2,465,000 | +49.1% | 336,286 | +108.5% | 1.69% | +106.9% |
| CYBX | New | CYBERONICS ORD | $2,460,000 | – | 40,478 | +100.0% | 1.69% | – |
| MRTX | Buy | MIRATI THERAPEUTICS ORD | $1,983,000 | +686.9% | 57,605 | +619.3% | 1.36% | +987.2% |
| NTUS | New | NATUS MEDICAL ORD | $1,973,000 | – | 50,000 | +100.0% | 1.35% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS ORD | $1,704,000 | – | 101,766 | +100.0% | 1.17% | – |
| HNGR | Sell | HANGER ORD | $1,255,000 | -69.6% | 91,995 | -47.7% | 0.86% | -57.8% |
| PETX | Sell | ARATANA THERAPEUTICS ORD | $1,186,000 | -80.6% | 140,156 | -65.4% | 0.81% | -73.1% |
| SCYX | SCYNEXIS ORD | $1,181,000 | -17.2% | 162,175 | 0.0% | 0.81% | +14.9% | |
| IRWD | Sell | IRONWOOD PHARMA CL A ORD | $1,119,000 | -60.8% | 107,400 | -54.7% | 0.77% | -45.7% |
| AGRX | Buy | AGILE THERAPEUTICS ORD | $536,000 | -0.4% | 79,567 | +27.1% | 0.37% | +38.0% |
| NSPR | New | INSPIREMD ORD | $357,000 | – | 2,166,446 | +100.0% | 0.24% | – |
| IMNP | New | IMMUNE PHARMACEUTICALS ORD | $233,000 | – | 197,655 | +100.0% | 0.16% | – |
| CXRX | New | CONCORDIA HEALTHCARE ORD | $221,000 | – | 5,201 | +100.0% | 0.15% | – |
| HART | Sell | HARVARD APPARATUS REGENERATIVE ORD | $99,000 | -70.3% | 116,593 | -49.9% | 0.07% | -58.8% |
| BIOD | Exit | BIODEL ORD | $0 | – | -160,523 | -100.0% | -0.08% | – |
| KMPH | Exit | KEMPHARM ORD | $0 | – | -27,543 | -100.0% | -0.25% | – |
| NSPR | Exit | INSPIREMD ORD | $0 | – | -2,166,446 | -100.0% | -0.30% | – |
| GSK | Exit | GLAXOSMITHKLINE ADR REP TWO ORDput | $0 | – | -50,000 | -100.0% | -1.03% | – |
| MDT | Exit | MEDTRONIC ORDput | $0 | – | -30,000 | -100.0% | -1.10% | – |
| HYH | Exit | HALYARD HEALTH ORD | $0 | – | -60,000 | -100.0% | -1.20% | – |
| ABT | Exit | ABBOTT LABORATORIES ORDput | $0 | – | -50,000 | -100.0% | -1.21% | – |
| LLY | Exit | ELI LILLY ORDput | $0 | – | -30,000 | -100.0% | -1.24% | – |
| IMMU | Exit | IMMUNOMEDICS ORDput | $0 | – | -664,900 | -100.0% | -1.33% | – |
| JNJ | Exit | JOHNSON & JOHNSON ORDput | $0 | – | -30,000 | -100.0% | -1.44% | – |
| SYK | Exit | STRYKER ORD | $0 | – | -33,300 | -100.0% | -1.57% | – |
| PFE | Exit | PFIZER ORDput | $0 | – | -150,000 | -100.0% | -2.48% | – |
| AET | Exit | AETNA ORD | $0 | – | -40,000 | -100.0% | -2.52% | – |
| ADUS | Exit | ADDUS HOMECARE ORD | $0 | – | -186,055 | -100.0% | -2.56% | – |
| GSK | Exit | GLAXOSMITHKLINE ORDadr | $0 | – | -255,000 | -100.0% | -5.25% | – |
| GILD | Exit | GILEAD SCIENCES ORDput | $0 | – | -500,000 | -100.0% | -28.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.